| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.39 | 3e-13 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.37 | 1e-12 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.39 | 4e-10 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.34 | 2e-08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |